These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Therapeutic potential of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors for the treatment of retinal and eye diseases. Schmeer C; Kretz A; Isenmann S CNS Neurol Disord Drug Targets; 2007 Aug; 6(4):282-7. PubMed ID: 17691985 [TBL] [Abstract][Full Text] [Related]
10. HMG CoA reductase inhibitors (statins): do they have a role in age-related macular degeneration? Guymer RH; Chiu AW; Lim L; Baird PN Surv Ophthalmol; 2005; 50(2):194-206. PubMed ID: 15749309 [TBL] [Abstract][Full Text] [Related]
11. Pleiotropic effects of statins: new therapeutic targets in drug design. Bedi O; Dhawan V; Sharma PL; Kumar P Naunyn Schmiedebergs Arch Pharmacol; 2016 Jul; 389(7):695-712. PubMed ID: 27146293 [TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory Effects of Statins in Lung Vascular Pathology: From Basic Science to Clinical Trials. Faraj R; Paine D; Black SM; Wang T Adv Exp Med Biol; 2021; 1303():33-56. PubMed ID: 33788186 [TBL] [Abstract][Full Text] [Related]